Plain-English translation of NCT07141225 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical technique for removing small kidney tumors (7 centimeters or smaller) using robot-assisted surgery. The approach being studied avoids clamping off the kidney's blood vessels during surgery and replaces traditional stitching with newer methods to control bleeding. The goal is to preserve as much healthy kidney tissue as possible and maintain kidney function after surgery.
Standard kidney tumor removal surgery requires clamping blood vessels and using complex multi-layer stitching, which can damage healthy kidney tissue and cause loss of kidney function in up to 30% of patients. This trial exists to see whether the newer approach—skipping the blood vessel clamp and using alternative bleeding-control methods—can be safer and preserve kidney function better.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo robot-assisted partial nephrectomy surgery using the new off-clamp, sutureless technique being studied. The surgical team will use the robot to remove your tumor while avoiding blood vessel clamping and traditional stitching. You will have standard pre-surgery evaluations and post-surgery follow-up care to monitor your kidney function and recovery.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China